PCJENAV Stock Latest News
Private CompaniesJenaValve Technology Inc – Weekly Recap3M agoJENAV
Private CompaniesJenaValve Highlights Untapped Aortic Regurgitation Treatment Market3M agoJENAV
Private CompaniesJenaValve Technology Inc – Weekly Recap6M agoJENAV
Private CompaniesJenaValve Highlights Trilogy System and AR Focus at EuroPCR 2026 Symposium6M agoJENAV
Private CompaniesJenaValve Promotes Trilogy System to Structural Heart Fellows at CRF 20266M agoJENAV
Private CompaniesJenaValve Expands Trilogy Heart Valve Use to Long Island Center6M agoJENAV
Private CompaniesJenaValve Expands Trilogy Heart Valve Availability With Long Island Adoption6M agoJENAV
Private CompaniesJenaValve Advances U.S. Rollout of Trilogy TAVR with New Site Adoptions6M agoJENAV
Private CompaniesJenaValve Expands Trilogy TAVR System Commercial Availability to Virginia6M agoJENAV
Private CompaniesJenaValve Expands Trilogy TAVR System Commercial Availability to Virginia6M agoJENAVPrivate CompaniesEarly Commercial Use of Trilogy System Marks Adoption Milestone for JenaValve6M agoJENAV
Private CompaniesEarly Commercial Adoption of Trilogy System at California Pacific Medical Center6M agoJENAV
Private CompaniesJenaValve Highlights FDA-Approved Trilogy System Ahead of AATS 20266M agoJENAV
Private CompaniesJenaValve Highlights FDA-Approved Trilogy System Ahead of AATS 20266M agoJENAV
Private CompaniesJenaValve Technology Showcases Early U.S. Adoption and FDA-Backed Trilogy TAVR Launch7M agoJENAV
Private CompaniesJenaValve’s Trilogy System Sees Initial Clinical Use at Scripps Health7M agoJENAVPrivate CompaniesJenaValve Technology Gains Momentum With Trilogy TAVR Adoption at Scripps Health7M agoJENAV
Private CompaniesJenaValve Emphasizes Trilogy Delivery System Features for TAVR Precision7M agoJENAV




